NovoCure Ltd — Director's Dealing 2018

Jun 5, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2018-05-31

Reporting Person: McCoy Sherilyn S (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-31	Options to Buy Ordinary Shares	$31.45	A	45137	Acquired	2028-05-31	Ordinary Shares (45137)	Direct

Footnotes

F1: This stock option will vest in equal parts on the earlier of each of the following dates: (i) the first, second and third anniversary of the grant date and (ii) the day immediately preceding of the Company's 2019, 2020 and 2021 annual general meeting of shareholders, respectively.